logo-loader
viewBiotechnology Innovation Organization

SFA Therapeutics developing its psoriasis therapy to showcase its anti-inflammatory platform

SFA Therapeutics, Inc CEO Dr. Ira Spector sat down with Proactive at the BIO Investor Forum in San Francisco. The Pennsylvania-based company, using microbiome-derived metabolites as drugs, is advancing its oral treatment for psoriasis into Phase 2 clinical studies.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Things coming together nicely in Greenland, says Bluejay Mining's CEO

Rod McIllree, Bluejay Mining PLC’s (LON:JAY) chief executive, tells Proactive that all three of its projects in Greenland are shaping up nicely with plenty of interest from mining giants. Dundas is the flagship and here a bulk sample of mineral sands has been shipped to a Rio Tinto facility...

2 days, 17 hours ago

2 min read